Hematopoietic Stem Cell Mobilization
Bioline Rx Ltd. is focused on clinical research in hematopoietic stem cell mobilization for autologous transplantation, with particular interest in improving the collection of peripheral blood stem cells for patients with multiple myeloma.
- CD34+ cell mobilization
- Peripheral blood stem cell collection
- Apheresis support
The sponsor’s research activity centers on enabling efficient stem cell harvesting in preparation for autologous hematopoietic cell transplantation.
Multiple Myeloma Supportive Care
The trial portfolio reflects a therapeutic interest in multiple myeloma, especially in the transplant pathway where stem cell mobilization is a critical step in treatment planning.
- Transplant preparation
- Cell collection efficiency
- Mobilization regimens
Clinical activity in this area is directed toward supporting patients who require autologous hematopoietic cell transplantation as part of their disease management.
Growth Factor-Based Mobilization
Bioline Rx Ltd. is involved in research combining G-CSF with investigational mobilization strategies to enhance stem cell yield in transplant candidates.
- Granulocyte colony-stimulating factor
- Stem cell yield
- Mobilization enhancement
This area highlights interest in biologic approaches that improve access to adequate CD34+ cell collections for transplantation.
Autologous Hematopoietic Cell Transplantation
The sponsor’s research is closely tied to the transplant process, with emphasis on supporting the collection of cells needed for auto-HCT in patients with multiple myeloma.
- Transplant eligibility support
- Cellular therapy preparation
- Blood stem cell procurement
Its funded study activity is centered on the clinical needs surrounding autologous transplantation rather than broader oncology indications.
